Stocks · News reference

United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia

Oct 1, 2026, 12:14 PMHenry Khederian

Shares of United Therapeutics are rising Thursday following a federal court victory in its patent litigation against competitor Liquidia.

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Oct 1, 2026, 12:14 PM
Checked: Oct 1, 2026, 12:14 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaOct 1, 2026, 4:59 PMBenzinga Newsdesk
United Therapeutics shares are trading higher after the company confirmed a patent litigation legal judgement in its favor in a claim against Liquidia. Also, BTIG upgraded its rating on the stock from Neutral to Buy and announced a $728 price target.
UTHR
BenzingaOct 1, 2026, 3:49 PMAvi Kapoor
This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Analysts upgraded BJRI, UTHR, OXY, BP and REGN, raising ratings and/or price targets.
BJRI BP OXY REGN UTHR
BenzingaOct 1, 2026, 12:01 PMAvi Kapoor
Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and other stocks also dropped in premarket trading.
CTVA IVA LGHL LQDA MI